Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Fall in Older Adults With Overactive Bladder
NCT03946124Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fesoterodine in overactive bladder (OAB), sponsored by University of Pennsylvania. Started Jul 2015; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03946124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03946124.